Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTH
3201
Faeth Therapeutics
FTH
$738M
| $2.88M | ﹤0.01% |
13,699
+6,609
| +93% | +$1.2M |
|
3202
Retractable Technologies
RVP
$20.3M
| $2.88M | ﹤0.01% |
260,755
+5,607
| +2% | +$65.6K |
|
3203
Kura Sushi USA
KRUS
$646M
| $2.87M | ﹤0.01% |
65,661
+6,177
| +10% | +$286K |
|
|
TIG
3204
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $2.87M | ﹤0.01% |
277,073
+2,247
| +0.8% | +$26.7K |
|
3205
GT Biopharma
GTBP
$10.7M
| $2.86M | ﹤0.01% |
14,143
+2,589
| +22% | +$779K |
|
3206
Mayville Engineering Co
MEC
$597M
| $2.86M | ﹤0.01% |
152,078
-84,305
| -36% | -$1.44M |
|
3207
AerSale
ASLE
$273M
| $2.85M | ﹤0.01% |
167,805
+368
| +0.2% | +$4.77K |
|
3208
HDFC Bank
HDB
$119B
| $2.83M | ﹤0.01% |
77,538
+702
| +0.9% | +$26K |
|
3209
Ternium
TX
$10.7B
| $2.83M | ﹤0.01% |
66,970
+13,750
| +26% | +$672K |
|
3210
Duluth Holdings
DLTH
$151M
| $2.83M | ﹤0.01% |
207,587
-1,239
| -0.6% | -$19.8K |
|
|
HOFV
3211
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
| $2.81M | ﹤0.01% |
48,204
+5,808
| +14% | +$389K |
|
3212
Village Super Market
VLGEA
$638M
| $2.8M | ﹤0.01% |
129,092
-2,350
| -2% | -$53K |
|
3213
Oil-Dri
ODC
$1.27B
| $2.79M | ﹤0.01% |
159,190
+662
| +0.4% | +$11.6K |
|
|
CSSE
3214
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
| $2.78M | ﹤0.01% |
121,594
-23,752
| -16% | -$683K |
|
3215
Immunic
IMUX
$226M
| $2.78M | ﹤0.01% |
31,395
+5,538
| +21% | +$545K |
|
3216
Clene
CLNN
$53.5M
| $2.77M | ﹤0.01% |
20,287
+167
| +0.8% | +$28.5K |
|
3217
McEwen Inc
MUX
$1.14B
| $2.77M | ﹤0.01% |
265,892
+5,978
| +2% | +$68.6K |
|
3218
Evolv Technologies
EVLV
$1.04B
| $2.76M | ﹤0.01% |
+460,307
| New | +$3.65M |
|
|
MPX
3219
DELISTED
Marine Products Corp
MPX
| $2.75M | ﹤0.01% |
219,670
-77,301
| -26% | -$1.13M |
|
|
PSTX
3220
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $2.75M | ﹤0.01% |
376,749
+205
| +0.1% | +$1.76K |
|
3221
PDS Biotechnology
PDSB
$13M
| $2.75M | ﹤0.01% |
184,244
+6,319
| +4% | +$78.8K |
|
3222
Aurinia Pharmaceuticals
AUPH
$2.02B
| $2.72M | ﹤0.01% |
123,110
-15,955
| -11% | -$253K |
|
|
EXPR
3223
DELISTED
Express, Inc.
EXPR
| $2.71M | ﹤0.01% |
28,701
+792
| +3% | +$87.2K |
|
3224
Avalo Therapeutics
AVTX
$1.04B
| $2.71M | ﹤0.01% |
431
-24
| -5% | -$195K |
|
3225
FTC Solar
FTCI
$40.1M
| $2.71M | ﹤0.01% |
34,739
+80
| +0.2% | +$8.08K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.